Chronic Obstructive Pulmonary Diseases:Journal of the COPD Foundation

Articles in Press

Peer-reviewed, accepted articles are posted in Articles in Press shortly after editorial acceptance. These posted articles (below) have completed a rigorous peer review process but the articles have NOT been copyedited or designed. Copyedited, designed, final versions of these articles will be created and published in a Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation (JCOPDF) upcoming issue. Articles in Press citations/abstracts are submitted to PubMed.

To receive notifications of the posting of new Articles in Press AND the posting of new JCOPDF issues, sign up for a FREE SUBSCRIPTION HERE.

KF4 Anti-Chymotrypsin-like Elastase 1 Antibody and Purified Alpha-1 Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine Alpha-1 Antitrypsin Deficiency

Andrew J. Devine, BS1* Noah J. Smith, BS2* Rashika Joshi, MD3 Brandon Brooks-Patton4 Jenna Dunham, BS4 Ansley N. Varisco5 Emily M. Goodman, MD6 Qiang Fan, PhD3 Basilia Zingarelli, MD, PhD3 Brian M. Varisco, MD1,2,6,7

Citation: Devine AJ, Smith NJ, Joshi R, et al. KF4 anti-chymotrypsin-like elastase 1 antibody and purified alpha-1 antitrypsin have similar but not additive efficacy in preventing emphysema in murine alpha-1 antitrypsin deficiency. Chronic Obstr Pulm Dis. 2024; Published online November 26, 2024. doi: https://doi.org/10.15326/jcopdf.2024.0535

View Pre-proof PDF

Telerehabilitation Services Remain Increased Post-COVID-19 in Australia

Anthony K. May, PhD1 Anne E. Holland, PhD1,2,3 Jennifer A. Alison, PhD4 Kelcie Herrmann5 Narelle S. Cox, PhD1,2

Citation: May AK, Holland AE, Alison JA, Herrmann K, Cox NS. Telerehabilitation services remain increased post-COVID-19 in Australia. Chronic Obstr Pulm Dis. 2024; Published online November 26, 2024. doi: https://doi.org/10.15326/jcopdf.2024.0575

View Pre-proof PDF

Impact of Pharmacist Inhaler Prescribing at Discharge for Chronic Obstructive Pulmonary Disease on Readmission Rates

Ana-Maria Diaz, PharmD1 Lindsey M. Smith, PharmD, BCACP, BCCP1 Amber N. Peterson, Pulmonary APRN1 Macie L. Kent, PharmD, CACP, CPh1 Namitha J. Vellian, PharmD1

Citation: Diaz AM, Smith LM, Peterson AN, Kent ML, Vellian NJ. Impact of pharmacist inhaler prescribing at discharge for chronic obstructive pulmonary disease on readmission rates. Chronic Obstr Pulm Dis. 2024; Published online November 26, 2024. doi: https://doi.org/10.15326/jcopdf.2024.0553

View Pre-proof PDF

Copyright 2024 by COPD Foundation Disclaimer| Privacy|

The COPD Foundation is a nonprofit, tax-exempt charitable organization under Section 501(c)(3) of the Internal Revenue Code.